Braeburn Pharmaceuticals

Patent cliffs & loss of exclusivity

Out licensing

Company

Company Operating StatusActive
Contact Page URLhttps://braeburnrx.com/contact-us/
Crunchbase URLhttps://www.crunchbase.com/organization/braeburn-pharmaceuticals
Email format{f}{last}
Full Address450 Plymouth Rd, Suite 400 Plymouth Meeting, PA 19462 USA
Instagram URLhttps://www.instagram.com/braeburnrx/
LinkedIn URLhttps://www.linkedin.com/company/braeburn
Seedtable URLhttps://seedtable.com/companies/braeburn-pharmaceuticals

7 upcoming patent cliffs

DrugIngredientTypeCliff
  1. BRIXADIBUPRENORPHINESmall mol.Jul 2032
  2. BRIXADIBUPRENORPHINESmall mol.Jul 2032
  3. BRIXADIBUPRENORPHINESmall mol.Jul 2032
  4. BRIXADIBUPRENORPHINESmall mol.Jul 2032
  5. BRIXADIBUPRENORPHINESmall mol.Jul 2032
  6. BRIXADIBUPRENORPHINESmall mol.Jul 2032
  7. BRIXADIBUPRENORPHINESmall mol.Jul 2032

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Not found